ACNT Ascent Industries Co. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
ACNT Stock | Fundamental Analysis & Investment Insights
NASDAQ
Basic Materials
Chemicals
Current Price
Live
$17.78
52W High
$17.85
52W Low
$10.97
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Feb 14, 2026
Market cap
$166.78M
P/E
N/A
ROE
-3.4%
Profit margin
0.5%
Debt/Equity
0.25
Dividend yield
N/A
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
ACNT exhibits severe financial distress signals, with a Piotroski F-Score of 2/9 indicating weak operational and financial health. The company reports negative operating margins, declining revenue, and a history of significant earnings misses, including a -2800% YoY EPS decline. Despite a seemingly strong current ratio (6.40), the lack of meaningful profitability and negative ROE (-3.38%) undermine balance sheet strength. Insider selling totaling $2.19M over six months further signals internal skepticism. The stock trades near its 52-week high, suggesting overvaluation relative to deteriorating fundamentals.
Key Strengths
Current ratio of 6.40 indicates strong short-term liquidity
Price/Sales of 0.97 suggests potential undervaluation relative to revenue
Recent 1-month price increase of 7.2% reflects short-term momentum
Low market cap ($0.17B) may attract speculative interest
Positive Q/Q EPS growth of 20.6% in the most recent quarter
Key Risks
Piotroski F-Score of 2/9 signals extreme financial weakness and poor operational efficiency
Negative operating margin (-2.09%) and declining revenue (-5.70% YoY) indicate deteriorating core business performance
Insider selling of $2.19M in six months reflects bearish sentiment from within the company
Historical earnings surprises average -286.69% over the last four quarters, indicating unreliable financial reporting
No analyst coverage or target price data, indicating low institutional interest and high uncertainty
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
22
Weak
45
20
30
15
0
AI Verdict
High Risk
Key drivers: Piotroski F-Score of 2/9, Negative operating margin and declining revenue, Significant insider selling, No analyst coverage, Historical earnings volatility and misses
Confidence
85%
Value
45/100
Ref P/E, PEG, Graham Number
Positives
- Price/Sales of 0.97 below sector average
- Current price near 52-week low relative to historical range
Watchpoints
- No Graham Number or intrinsic value estimate available
- Forward P/E of 22.23 is high given negative earnings and declining growth
- Price near 52-week high ($17.85) despite weak fundamentals
Future
20/100
Ref Growth rates
Positives
- Q/Q EPS growth of +20.6% in most recent quarter
Watchpoints
- Revenue growth down 5.70% YoY
- Earnings growth down -2800% YoY
- No forward guidance or analyst estimates available
- Negative ROIC and declining profitability
Past
30/100
Ref Historical trends
Positives
- Historical periods of strong EPS beats (e.g., 2015-2014)
- Some quarters with positive surprises (e.g., +200% in 2015)
Watchpoints
- Last 4 quarters all missed estimates
- Average earnings surprise of -286.69% over last 4 quarters
- Persistent negative operating margins and ROE
- Declining revenue trend over multiple years
Health
15/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Debt/Equity ratio of 0.25 is low
- Current ratio of 6.40 and quick ratio of 5.33 indicate strong liquidity
Watchpoints
- Piotroski F-Score of 2/9 indicates severe financial distress
- Negative ROE (-3.38%) and ROA (0.02%) reflect poor capital efficiency
- No Altman Z-Score available, but F-Score of 2 suggests high bankruptcy risk
- Negative operating margin and declining profitability
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- Dividend yield and payout ratio are both 0
- No history of dividend payments
- Negative earnings preclude sustainable dividend
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$17.78
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ACNT and closest competitors.
Updated 2026-02-13
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ACNT
Ascent Industries Co.
Primary
|
+110.2% | +56.0% | +61.0% | +48.7% | +7.2% | +3.4% |
|
AVD
American Vanguard Corporation
Peer
|
-72.7% | -78.1% | -12.5% | +31.6% | +23.4% | +14.2% |
|
ALTO
Alto Ingredients, Inc.
Peer
|
-64.8% | -20.7% | +73.2% | +156.6% | +13.3% | +8.8% |
|
AMTX
Aemetis, Inc.
Peer
|
-83.1% | -63.3% | -34.2% | -53.3% | +8.0% | 0.0% |
|
BIOX
Bioceres Crop Solutions Corp.
Peer
|
-85.0% | -90.1% | -82.5% | -68.0% | -11.8% | -7.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
22.23
PEG Ratio
N/A
P/B Ratio
1.91
P/S Ratio
0.97
EV/Revenue
0.76
EV/EBITDA
18.03
Market Cap
$166.78M
Profitability
Profit margins and return metrics
Profit Margin
0.51%
Operating Margin
-2.09%
Gross Margin
16.73%
ROE
-3.38%
ROA
0.02%
Growth
Revenue and earnings growth rates
Revenue Growth
-5.7%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.25
Low debt
Current Ratio
6.4
Strong
Quick Ratio
5.33
Excellent
Cash/Share
$6.2
Quarterly Earnings History
EPS performance vs analyst estimates
2026-03-04
$N/A
2024-05-08
$-0.54
-46.0% surprise
2024-03-28
$-0.68
-743.9% surprise
2023-11-08
$-0.2
-70.3% surprise
Basic Materials Sector Comparison
Comparing ACNT against 41 companies in the Basic Materials sector
(1 bullish, 20 neutral, 20 bearish)
Return on Equity (ROE)
-3.38%
This Stock
vs
-0.24%
Sector Avg
+1304.9%
(Excellent)
Profit Margin
0.51%
This Stock
vs
-2.71%
Sector Avg
-118.9%
(Weaker)
Debt to Equity
0.25
This Stock
vs
0.61
Sector Avg
-59.7%
(Less Debt)
Revenue Growth
-5.7%
This Stock
vs
14.52%
Sector Avg
-139.2%
(Slower)
Current Ratio
6.4
This Stock
vs
2.29
Sector Avg
+179.2%
(Stronger)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ACNT
Ascent Industries Co.
|
BEARISH | $166.78M | - | -3.4% | 0.5% | $17.78 | |
|
AVD
American Vanguard Corporation
|
BEARISH | $139.78M | - | -40.8% | -21.1% | $4.91 | |
|
ALTO
Alto Ingredients, Inc.
|
BEARISH | $210.52M | - | -20.6% | -5.4% | $2.72 | |
|
AMTX
Aemetis, Inc.
|
BEARISH | $98.64M | - | -% | -43.6% | $1.49 | |
|
BIOX
Bioceres Crop Solutions Corp.
|
BEARISH | $76.17M | - | -18.9% | -17.7% | $1.2 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-22 | KAVALAUSKAS RYAN | Chief Financial Officer | Stock Award | 2,508 | $41,244 |
| 2026-01-22 | KITCHEN JOHN BRYAN | Chief Executive Officer | Stock Award | 9,081 | $149,337 |
| 2025-12-02 | KAVALAUSKAS RYAN | Chief Financial Officer | Stock Award | 2,508 | $37,532 |
| 2025-12-02 | KITCHEN JOHN BRYAN | Chief Executive Officer | Stock Award | 9,082 | $135,912 |
| 2025-09-11 | HUTTER CHRISTOPHER GERALD | Director | Sale | 47,935 | $587,204 |
| 2025-09-10 | HUTTER CHRISTOPHER GERALD | Director | Sale | 40,000 | $495,200 |
| 2025-09-08 | PAN ANTHONY X | Divisional Officer | Stock Award | 3,075 | $37,407 |
| 2025-09-08 | SRINIVAS RAVI RAMESH | Divisional Officer | Stock Award | 2,820 | $34,305 |
| 2025-09-08 | SHAH HARSHIL VIPUL | Divisional Officer | Stock Award | 3,606 | $43,867 |
| 2025-09-08 | PORTNOY KIMBERLY | General Counsel | Stock Award | 3,606 | $43,867 |
| 2025-09-08 | HERRING KENNETH WAYNE JR | Controller | Stock Award | 2,295 | $27,919 |
| 2025-08-28 | HUTTER CHRISTOPHER GERALD | Director | Sale | 2,100 | $25,347 |
| 2025-08-26 | HUTTER CHRISTOPHER GERALD | Director | Sale | 9,326 | $112,099 |
| 2025-08-25 | HUTTER CHRISTOPHER GERALD | Director | Sale | 40,000 | $484,800 |
| 2025-08-22 | HUTTER CHRISTOPHER GERALD | Director | Sale | 40,000 | $484,400 |
Insider transactions can signal confidence or concerns about company prospects
Past News Coverage
Recent headlines mentioning ACNT from our newsroom.
Newest → oldest
No matching news yet.